Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High‐Risk Vascular Disease Treated With Statin Therapy

BACKGROUND: The contemporary impact of glycemic control on patients with diabetes mellitus at high cardiovascular risk remains unclear. We evaluated the utility of hemoglobin A1c (HbA1c) as a marker of risk on the composite end point of cardiovascular death, nonfatal myocardial infarction, stroke, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Menon, Venu, Kumar, Anirudh, Patel, Divyang R., John, Julie St., Wolski, Kathy E., McErlean, Ellen, Riesmeyer, Jeffrey S., Weerakkody, Govinda, Ruotolo, Giacomo, Cremer, Paul C., Nicholls, Stephen J., Lincoff, A. Michael, Nissen, Steven E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988169/
https://www.ncbi.nlm.nih.gov/pubmed/31852422
http://dx.doi.org/10.1161/JAHA.119.014328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988169/
https://www.ncbi.nlm.nih.gov/pubmed/31852422
http://dx.doi.org/10.1161/JAHA.119.014328

Ejemplares similares